The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan
The journey to implement cancer genomic medicine (CGM) in oncology practice began in the 1980s, which is considered the dawn of genetic and genomic cancer research. At the time, a variety of activating oncogenic alterations and their functional significance were unveiled in cancer cells, which led t...
Main Authors: | Teruhiko Yoshida, Yasushi Yatabe, Ken Kato, Genichiro Ishii, Akinobu Hamada, Hiroyuki Mano, Kuniko Sunami, Noboru Yamamoto, Takashi Kohno |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2024-01-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/21/1/29 |
Similar Items
-
The Mexican Biobank Project promotes genetic discovery, inclusive science and local capacity building
by: Mashaal Sohail, et al.
Published: (2024-01-01) -
Motivations and Barriers to Sharing Biological Samples: A Case Study
by: Stacey Pereira
Published: (2013-06-01) -
Access, autonomy, and affordability: ethical and human rights issues surrounding multigene panel testing for cancer in Japan and Switzerland
by: Kate Nakasato, et al.
Published: (2024-01-01) -
Ethical considerations for biobanking and use of genomics data in Africa: a narrative review
by: Mary Amoakoh-Coleman, et al.
Published: (2023-12-01) -
A cervical cancer biorepository for pharmacogenomics research in Zimbabwe
by: Oppah Kuguyo, et al.
Published: (2022-12-01)